EAU 2025 | The importance of gender-neutral HPV vaccination

Peter Baker • 6 Mar 2025

EAU 2025

General

Peter Baker, Global Action on Men’s Health, London, UK, discusses the necessity for human papillomavirus (HPV) vaccination in males and females to prevent anogenital and head and neck cancers, and other non-cancerous conditions. Since males carry a significantly higher risk of contracting cancer-causing HPV, is it paramount that vaccination extends beyond cervical cancer prevention to protect both males and females. This interview took place at the 2025 European Association of Urology (EAU) Congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.